Cesar Serrano (Cèsar Serrano, César Serrano)

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 30

Top Venues

Nature medicine

Expert opinion on investigational drugs

Clinical cancer research : an official journal of the American Association for Cancer Research

Cancer gene therapy

Vall d´Hebron Institut d´Oncologia

Autonomous University of Barcelona (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Vall d´Hebron Institut d´Oncologia

Spain

Head of Group :: Sarcoma Translational Research Lab

Hospital Vall d'Hebron Aug 01 2014

Spain

Attending physician :: Medical Oncology/Sarcoma Unit

Vall d'Hebron Insitute of Oncology

Spain

Research scientist :: Growth Factors Laboratory

Education History

Autonomous University of Barcelona

Spain

PHD :: Department of Medicine

Publications

Carlo María Cicala, Iván Olivares-Rivas, Jon Ander Aguirre-Carrillo, Cesar Serrano
KIT/PDGFRA inhibitors for the treatment of gastrointestinal stromal tumors: getting to the gist of the problem. Expert opinion on investigational drugs (2024)
Suzanne George, Jean Yves Blay, Ping Chi, Robin L Jones, Cesar Serrano, Neeta Somaiah, André B P van Kuilenburg, Zalcberg John, William Reichmann, Kam Sprott, Paulina Cox, Matthew L Sherman, Rodrigo Ruiz-Soto, Michael C Heinrich, Sebastian Bauer
The INSIGHT study: a randomized, Phase III study of ripretinib versus sunitinib for advanced gastrointestinal stromal tumor with KIT exon 11 + 17/18 mutations. Future oncology (London, England) (2024)
Michael C Heinrich, Robin L Jones, Suzanne George, André B P van Kuilenburg, Patrick Schöffski, Margaret von Mehren, John R Zalcberg, Yoon-Koo Kang, Albiruni Abdul Razak, Jonathan Trent, Steven Attia, Axel Le Cesne, Brittany L Siontis, David Goldstein, Kjetil Boye, Cesar Sanchez, Neeltje Steeghs, Piotr Rutkowski, Mihaela Druta, Cesar Serrano, Neeta Somaiah, Ping Chi, William Reichmann, Kam Sprott, Haroun Achour, Matthew L Sherman, Rodrigo Ruiz-Soto, Jean Yves Blay, Sebastian Bauer
Ripretinib versus sunitinib in gastrointestinal stromal tumor: ctDNA biomarker analysis of the phase 3 INTRIGUE trial. Nature medicine 30 (2) (2024)
Carlo María Cicala, Iván Olivares-Rivas, Jon Ander Aguirre-Carrillo, Cesar Serrano
KIT/PDGFRA inhibitors for the treatment of gastrointestinal stromal tumors: getting to the gist of the problem. Expert opinion on investigational drugs (2024)
Michael C Heinrich, Robin L Jones, Suzanne George, André B P van Kuilenburg, Patrick Schöffski, Margaret von Mehren, John R Zalcberg, Yoon-Koo Kang, Albiruni Abdul Razak, Jonathan Trent, Steven Attia, Axel Le Cesne, Brittany L Siontis, David Goldstein, Kjetil Boye, Cesar Sanchez, Neeltje Steeghs, Piotr Rutkowski, Mihaela Druta, Cesar Serrano, Neeta Somaiah, Ping Chi, William Reichmann, Kam Sprott, Haroun Achour, Matthew L Sherman, Rodrigo Ruiz-Soto, Jean Yves Blay, Sebastian Bauer
Ripretinib versus sunitinib in gastrointestinal stromal tumor: ctDNA biomarker analysis of the phase 3 INTRIGUE trial. Nature medicine 30 (2) (2024)
Michael C Heinrich, Robin L Jones, Suzanne George, André B P van Kuilenburg, Patrick Schöffski, Margaret von Mehren, John R Zalcberg, Yoon-Koo Kang, Albiruni Abdul Razak, Jonathan Trent, Steven Attia, Axel Le Cesne, Brittany L Siontis, David Goldstein, Kjetil Boye, Cesar Sanchez, Neeltje Steeghs, Piotr Rutkowski, Mihaela Druta, Cesar Serrano, Neeta Somaiah, Ping Chi, William Reichmann, Kam Sprott, Haroun Achour, Matthew L Sherman, Rodrigo Ruiz-Soto, Jean Yves Blay, Sebastian Bauer
Ripretinib versus sunitinib in gastrointestinal stromal tumor: ctDNA biomarker analysis of the phase 3 INTRIGUE trial. Nature medicine 30 (2) (2024)
Francisco Cristóbal Muñoz-Casares, Javier Martín-Broto, Pedro Cascales-Campos, Juan Torres-Melero, Irene López-Rojo, José Gómez-Barbadillo, Luis González-Bayón, Ana Sebio, Cesar Serrano, Sara Carvalhal, Joaquim Abreu de Souza, Alexandre Souza, Guillermo Flores-Ayala, Luis José Palacios Fuenmayor, Raquel Lopes-Brás, José Antonio González-López, Hugo Vasques, José Manuel Asencio
Ibero-American Consensus for the Management of Peritoneal Sarcomatosis: Updated Review and Clinical Recommendations. Cancers 16 (15) (2024)
Javier Carmona, Elena Chavarria, Kate Donoghue, Christina von Gertten, Petra Oberrauch, Emma Pailler, Giovanni Scoazec, Ruud Weijer, Judith Balmaña, Irene Brana, Cinzia Brunelli, Suzette Delaloge, Marc Deloger, Pierre Delpy, Ingemar Ernberg, Rebecca C Fitzgerald, Elena Garralda, Martin Lablans, Janne Lehtiö, Carlos Lopez, Maialen Fernández, Rosalba Miceli, Paolo G Nuciforo, Raquel Perez-Lopez, Elena Provenzano, Marjanka K Schmidt, Cesar Serrano, Neeltje Steeghs, David Tamborero, Valtteri Wirta, Richard D Baird, Karen Barker, Fabrice Barlesi, Michael Baumann, Jonas Bergh, Filippo G De Braud, Karim Fizazi, Stefan Fröhling, Alejandro Piris-Giménez, Kenneth Seamon, Michiel S Van Der Heijden, Wilbert Zwart, Josep Tabernero
Cancer Core Europe: Leveraging Institutional Synergies to Advance Oncology Research and Care Globally. Cancer discovery 14 (7) (2024)
Michael C Heinrich, Robin L Jones, Suzanne George, André B P van Kuilenburg, Patrick Schöffski, Margaret von Mehren, John R Zalcberg, Yoon-Koo Kang, Albiruni Abdul Razak, Jonathan Trent, Steven Attia, Axel Le Cesne, Brittany L Siontis, David Goldstein, Kjetil Boye, Cesar Sanchez, Neeltje Steeghs, Piotr Rutkowski, Mihaela Druta, Cesar Serrano, Neeta Somaiah, Ping Chi, William Reichmann, Kam Sprott, Haroun Achour, Matthew L Sherman, Rodrigo Ruiz-Soto, Jean Yves Blay, Sebastian Bauer
Ripretinib versus sunitinib in gastrointestinal stromal tumor: ctDNA biomarker analysis of the phase 3 INTRIGUE trial. Nature medicine 30 (2) (2024)
Michael C Heinrich, Robin L Jones, Suzanne George, André B P van Kuilenburg, Patrick Schöffski, Margaret von Mehren, John R Zalcberg, Yoon-Koo Kang, Albiruni Abdul Razak, Jonathan Trent, Steven Attia, Axel Le Cesne, Brittany L Siontis, David Goldstein, Kjetil Boye, Cesar Sanchez, Neeltje Steeghs, Piotr Rutkowski, Mihaela Druta, Cesar Serrano, Neeta Somaiah, Ping Chi, William Reichmann, Kam Sprott, Haroun Achour, Matthew L Sherman, Rodrigo Ruiz-Soto, Jean Yves Blay, Sebastian Bauer
Ripretinib versus sunitinib in gastrointestinal stromal tumor: ctDNA biomarker analysis of the phase 3 INTRIGUE trial. Nature medicine 30 (2) (2024)
Michael C Heinrich, Robin L Jones, Suzanne George, André B P van Kuilenburg, Patrick Schöffski, Margaret von Mehren, John R Zalcberg, Yoon-Koo Kang, Albiruni Abdul Razak, Jonathan Trent, Steven Attia, Axel Le Cesne, Brittany L Siontis, David Goldstein, Kjetil Boye, Cesar Sanchez, Neeltje Steeghs, Piotr Rutkowski, Mihaela Druta, Cesar Serrano, Neeta Somaiah, Ping Chi, William Reichmann, Kam Sprott, Haroun Achour, Matthew L Sherman, Rodrigo Ruiz-Soto, Jean Yves Blay, Sebastian Bauer
Ripretinib versus sunitinib in gastrointestinal stromal tumor: ctDNA biomarker analysis of the phase 3 INTRIGUE trial. Nature medicine 30 (2) (2024)
Francisco Cristóbal Muñoz-Casares, Javier Martín-Broto, Pedro Cascales-Campos, Juan Torres-Melero, Irene López-Rojo, José Gómez-Barbadillo, Luis González-Bayón, Ana Sebio, Cesar Serrano, Sara Carvalhal, Joaquim Abreu de Souza, Alexandre Souza, Guillermo Flores-Ayala, Luis José Palacios Fuenmayor, Raquel Lopes-Brás, José Antonio González-López, Hugo Vasques, José Manuel Asencio
Ibero-American Consensus for the Management of Peritoneal Sarcomatosis: Updated Review and Clinical Recommendations. Cancers 16 (15) (2024)
Michael C Heinrich, Robin L Jones, Suzanne George, André B P van Kuilenburg, Patrick Schöffski, Margaret von Mehren, John R Zalcberg, Yoon-Koo Kang, Albiruni Abdul Razak, Jonathan Trent, Steven Attia, Axel Le Cesne, Brittany L Siontis, David Goldstein, Kjetil Boye, Cesar Sanchez, Neeltje Steeghs, Piotr Rutkowski, Mihaela Druta, Cesar Serrano, Neeta Somaiah, Ping Chi, William Reichmann, Kam Sprott, Haroun Achour, Matthew L Sherman, Rodrigo Ruiz-Soto, Jean Yves Blay, Sebastian Bauer
Ripretinib versus sunitinib in gastrointestinal stromal tumor: ctDNA biomarker analysis of the phase 3 INTRIGUE trial. Nature medicine (2024)
Javier Carmona, Elena Chavarria, Kate Donoghue, Christina von Gertten, Petra Oberrauch, Emma Pailler, Giovanni Scoazec, Ruud Weijer, Judith Balmaña, Irene Brana, Cinzia Brunelli, Suzette Delaloge, Marc Deloger, Pierre Delpy, Ingemar Ernberg, Rebecca C Fitzgerald, Elena Garralda, Martin Lablans, Janne Lehtiö, Carlos Lopez, Maialen Fernández, Rosalba Miceli, Paolo G Nuciforo, Raquel Perez-Lopez, Elena Provenzano, Marjanka K Schmidt, Cesar Serrano, Neeltje Steeghs, David Tamborero, Valtteri Wirta, Richard D Baird, Karen Barker, Fabrice Barlesi, Michael Baumann, Jonas Bergh, Filippo G De Braud, Karim Fizazi, Stefan Fröhling, Alejandro Piris-Giménez, Kenneth Seamon, Michiel S Van Der Heijden, Wilbert Zwart, Josep Tabernero
Cancer Core Europe: Leveraging Institutional Synergies to Advance Oncology Research and Care Globally. Cancer discovery (2024)
Carlo María Cicala, Iván Olivares-Rivas, Jon Ander Aguirre-Carrillo, Cesar Serrano
KIT/PDGFRA inhibitors for the treatment of gastrointestinal stromal tumors: getting to the gist of the problem. Expert opinion on investigational drugs 33 (3) (2024)
Carlo María Cicala, Iván Olivares-Rivas, Jon Ander Aguirre-Carrillo, Cesar Serrano
KIT/PDGFRA inhibitors for the treatment of gastrointestinal stromal tumors: getting to the gist of the problem. Expert opinion on investigational drugs 33 (3) (2024)
Bruna Bianca Lopes David, Pedro Nazareth Aguiar, Matheus Costa E Silva, Rodrigo Dienstmann, Carlos Gil Ferreira, Cesar Serrano
Cost Evaluation Analysis of Genetic Testing and Tailored Adjuvant Imatinib in Patients With Resected High-Risk GI Stromal Tumors: The Brazilian Perspective. JCO global oncology 9 (2023)
Michael C Heinrich, Xinhua Zhang, Robin L Jones, Suzanne George, Cesar Serrano, Yan-Hong Deng, Sebastian Bauer, Shirong Cai, Xin Wu, Yongjian Zhou, Kaixiong Tao, Zhi-Chao Zheng, Jun Zhang, Yuehong Cui, Hui Cao, Meining Wang, Jin Hu, Jason Yang, Jian Li, Lin Shen
Clinical Benefit of Avapritinib in KIT-Mutant Gastrointestinal Stromal Tumors: A Post Hoc Analysis of the Phase I NAVIGATOR and Phase I/II CS3007-001 Studies. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Cesar Serrano, Sara Rothschild, Guillermo Villacampa, Michael C Heinrich, Suzanne George, Jean Yves Blay, Jason K Sicklick, Gary K Schwartz, Sameer Rastogi, Robin L Jones, Piotr Rutkowski, Neeta Somaiah, Víctor Navarro, Denisse Evans, Jonathan C Trent
Rethinking placebos: embracing synthetic control arms in clinical trials for rare tumors. Nature medicine (2023)
Elizabeth Proaño-Pérez, Eva Serrano-Candelas, Alfonso García-Valverde, Jordi Rosell, David Gómez-Peregrina, Arnau Navinés-Ferrer, Mario Guerrero, Cesar Serrano, Margarita Martín
The microphthalmia-associated transcription factor is involved in gastrointestinal stromal tumor growth. Cancer gene therapy (2022)
Gloria Ravegnini, Bruno Fosso, Riccardo Ricci, Francesca Gorini, Silvia Turroni, Cesar Serrano, Daniel F Pilco-Janeta, Qianqian Zhang, Federica Zanotti, Mariangela De Robertis, Margherita Nannini, Maria Abbondanza Pantaleo, Raffaella Arfè, Sabrina Angelini
Analysis of microbiome in gastrointestinal stromal tumors: Looking for different players in tumorigenesis and novel therapeutic options. Cancer science 113 (8) (2022)
Elizabeth Proaño-Pérez, Eva Serrano-Candelas, Alfonso García-Valverde, Jordi Rosell, David Gómez-Peregrina, Arnau Navinés-Ferrer, Mario Guerrero, Cesar Serrano, Margarita Martín
Correction to: The microphthalmia-associated transcription factor is involved in gastrointestinal stromal tumor growth. Cancer gene therapy (2022)
Sebastian Bauer, Michael C Heinrich, Suzanne George, Zalcberg John, Cesar Serrano, André B P van Kuilenburg, Robin L Jones, Steven Attia, Gina D'Amato, Ping Chi, Peter Reichardt, Julie Meade, Ying Su, Rodrigo Ruiz-Soto, Jean Yves Blay, Margaret von Mehren, Patrick Schöffski
Clinical Activity of Ripretinib in Patients with Advanced Gastrointestinal Stromal Tumor Harboring Heterogeneous KIT/PDGFRA Mutations in the Phase III INVICTUS Study. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (23) (2021)
Gloria Ravegnini, Cesar Serrano, Riccardo Ricci, Qianqian Zhang, Irene Terrenato, Agnese Graziosi, Giorgia Valori, Stefania Landolfi, Raffaella Arfè, Sabrina Angelini
miRNA landscape in primary tumors and matched metastases in gastrointestinal stromal tumors. Epigenomics 13 (5) (2021)
David Gómez-Peregrina, Alfonso García-Valverde, Daniel Pilco-Janeta, Cesar Serrano
Liquid Biopsy in Gastrointestinal Stromal Tumors: Ready for Prime Time? Current treatment options in oncology 22 (4) (2021)
Alfonso García-Valverde, Jordi Rosell, Sergi Sayols, David Gómez-Peregrina, Daniel F Pilco-Janeta, Iván Olivares-Rivas, Enrique de Álava, Joan Maurel, Jordi Rubió-Casadevall, Anna Esteve, Marta Gut, Claudia Valverde, Jordi Barretina, Joan Carles, George D Demetri, Jonathan A Fletcher, Joaquín Arribas, Cesar Serrano
E3 ubiquitin ligase Atrogin-1 mediates adaptive resistance to KIT-targeted inhibition in gastrointestinal stromal tumor. Oncogene 40 (48) (2021)
Anu Gupta, Jarnail Singh, Alfonso García-Valverde, Cesar Serrano, Daniel L Flynn, Bryan D Smith
Ripretinib and MEK Inhibitors Synergize to Induce Apoptosis in Preclinical Models of GIST and Systemic Mastocytosis. Molecular cancer therapeutics 20 (7) (2021)
Cesar Serrano, Ana Vivancos, Antonio López-Pousa, Judit Matito, Francesco M Mancuso, Claudia Valverde, Sergi Quiroga, Stefania Landolfi, Sandra Castro, Cristina Dopazo, Ana Sebio, Anna C Virgili, María M Menso, Javier Martín-Broto, Miriam Sansó, Alfonso García-Valverde, Jordi Rosell, Jonathan A Fletcher, Suzanne George, Joan Carles, Joaquín Arribas
Clinical value of next generation sequencing of plasma cell-free DNA in gastrointestinal stromal tumors. BMC cancer 20 (1) (2020)
Cesar Serrano, Suzanne George
Gastrointestinal Stromal Tumor: Challenges and Opportunities for a New Decade. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (19) (2020)
Cesar Serrano, Xavier García-Del-Muro, Claudia Valverde, Ana Sebio, José Durán, Aránzazu Manzano, Isabel Pajares, Nadia Hindi, Stefania Landolfi, Laura Jiménez, Jordi Rubió-Casadevall, Anna Estival, Javier Lavernia, María José Safont, Carles Pericay, Roberto Díaz-Beveridge, Virginia Martínez-Marín, David Vicente-Baz, Ana Vivancos, Javier Hernández-Losa, Joaquín Arribas, Joan Carles
Clinicopathological and Molecular Characterization of Metastatic Gastrointestinal Stromal Tumors with Prolonged Benefit to Frontline Imatinib. The oncologist 24 (5) (2018)

Cesar Serrano.css-eqlu8i{font-size:small;padding-left:4px;} (Cèsar Serrano, César Serrano)

Publication Activity (10 Years)

Top Topics

Top Venues

Cesar Serrano (Cèsar Serrano, César Serrano)